Mechanism of Action
Secretin Receptor Signaling
Secretin binds a Gs-coupled GPCR expressed in pancreatic ductal cells, biliary epithelium, gastric mucosa, kidney, and brain. Receptor activation increases intracellular cAMP, activating PKA and CFTR chloride channels in pancreatic duct cells. This drives bicarbonate and fluid secretion into pancreatic juice, raising luminal pH to neutralize acid chyme entering the duodenum.
Gastric Inhibition
Secretin inhibits gastrin release from antral G-cells and reduces gastric acid secretion, creating a negative feedback loop that protects the duodenal mucosa from prolonged acid exposure. Secretin also delays gastric emptying via pyloric sphincter contraction, coordinating gastric output with duodenal processing capacity.
CNS Roles
Secretin receptors are expressed in the cerebellum, hypothalamus, amygdala, and choroid plexus. In the choroid plexus, secretin regulates CSF production volume. In the hypothalamus, secretin modulates water intake and osmoregulation. Brain secretin may play a role in social behavior and autism-related circuitry, driving clinical trials of IV secretin in ASD.
Research Summary
Pancreatic Diagnostic Testing
HumanIV secretin stimulation is the gold standard test for exocrine pancreatic insufficiency (EPI) via secretin-stimulated ERCP or magnetic resonance pancreatography. The secretin stimulation test measures peak bicarbonate concentration and volume output from pancreatic ducts, enabling precise diagnosis of chronic pancreatitis and other EPI causes.
Autism Spectrum Disorder
HumanFollowing anecdotal reports of behavioral improvement in autistic children receiving secretin for GI diagnostic procedures, multiple controlled trials tested IV secretin as an autism treatment. Meta-analyses of these trials found no consistent benefit over placebo for core ASD symptoms, though ongoing research examines secretin's central mechanisms.
Neuroprotection and Water Homeostasis
AnimalAnimal studies show secretin reduces brain edema after injury through aquaporin-4 regulation in astrocytes. Secretin knockout mice display altered CSF volume and osmolar homeostasis, supporting a physiological role in brain water balance with potential therapeutic implications for conditions involving cerebral edema.
Calculate your Secretin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Pancreatic function testing | 0.2-0.4 mcg/kg | Single IV dose | Intravenous (1 min) |
| CNS / neuroprotection research | 10-100 mcg/kg | Variable | IV or SC (animal) |
Human secretin (ChiRhoStim) is the approved form for diagnostic use. Research doses for CNS studies differ from diagnostic protocols.
Interactions
Safety Profile
Human secretin has an excellent safety record from decades of diagnostic clinical use. Transient flushing, nausea, and abdominal cramping are the most common effects at diagnostic doses. Allergic reactions are rare. The half-life of ~45 minutes limits prolonged effects. No significant toxicity has been identified in extensive clinical use across all age groups including infants.
References
- [1]Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol. 1902;28(5):325-353.
- [2]Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. Eur J Biochem. 1968;6(1):156-162.
- [3]Chu JY, et al. Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci. 2009.